The latest news from British Patient Capital
Press release 04 November 2024
British Patient Capital – Full Year Results for the period ending 31 March 2024
Driving long-term growth: British Patient Capital’s total fund and co-investment commitments reach £2.3 billion, retaining its position as the UK’s largest domestic investor in venture and venture growth capital. Total assets under management have now reached £3.125 billion.
Filter Close filters
Displaying 21 - 30 of 95 results
Filter news
Showing 21 - 30 of 95 results
-
British Patient Capital announces $50.8m commitment to Evolution Technology Fund IIIPress release
25 April 2024 - British Patient Capital announces £7m investment in Financial Wellbeing Fintech - Wagestream
Press release
17 April 2024 -
British Patient Capital announces £5.5m commitment to PhagenesisPress release
04 March 2024 - British Patient Capital announces £10m investment into Curve Therapeutics
Press release
27 February 2024 -
British Patient Capital announces €20m commitment to Earlybird Health IIPress release
14 February 2024 -
British Patient Capital announces £20m commitment to Episode 1’s Fund IIIPress release
06 February 2024 -
British Patient Capital Invests £5.5m in Pragmatic SemiconductorPress release
06 December 2023 -
British Patient Capital announces £25m commitment to Oxx IIPress release
29 November 2023 -
British Patient Capital – Full Year Results for the period ending 31 March 2023Press release
27 November 2023 -
British Patient Capital Response to Nations and Regions Tracker 2023Press release
12 October 2023